## **Core Concept**
Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, also known as C cells, which produce **calcitonin**. This cancer can occur sporadically or as part of hereditary syndromes such as Multiple Endocrine Neoplasia (MEN) 2A and 2B, and Familial Medullary Thyroid Carcinoma (FMTC).

## **Why the Correct Answer is Right**
The correct answer, ., implies that the statement regarding medullary thyroid carcinoma being associated with **high levels of thyroglobulin** is not true. Medullary thyroid carcinoma originates from C cells, which do not produce thyroglobulin, a protein produced by the follicular cells of the thyroid gland. Therefore, MTC is characterized by **low or undetectable levels of thyroglobulin**, making this statement correct in the context of what is not true about MTC.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because MTC is indeed associated with **elevated calcitonin levels**, which serve as a tumor marker for diagnosis and follow-up.
- **Option B:** This option is incorrect as MTC can occur **sporadically** or as part of hereditary syndromes, making familial occurrence a recognized aspect of the disease.
- **Option C:** This option is incorrect because **RET proto-oncogene mutations** are associated with both sporadic and familial forms of MTC, playing a critical role in its pathogenesis.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **calcitonin and carcinoembryonic antigen (CEA) levels** are used as tumor markers for medullary thyroid carcinoma. Elevated levels can indicate disease recurrence or metastasis.

## **Correct Answer: D. high levels of thyroglobulin**